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Abstract
The remarkable increase in chondrocyte volume is a major
determinant in the longitudinal growth of mammalian
bones. To permit a detailed morphological study of
hypertrophic chondrocytes using standard histological
techniques, the preservation of normal chondrocyte
morphology is essential. We noticed that during fixation of
growth plates with conventional fixative solutions, there
was a marked morphological (shrinkage) artifact, and we
postulated that this arose from the hyper-osmotic nature of
these solutions.  To test this, we fixed proximal tibia growth
plates of 7-day-old rat bones in either (a) paraformaldehyde
(PFA; 4%), (b) glutaraldehyde (GA; 2%) with PFA (2%)
with ruthenium hexamine trichloride (RHT; 0.7%), (c) GA
(2%) with RHT (0.7%), or (d) GA (1.3%) with RHT (0.5%)
and osmolarity adjusted to a ‘physiological’ level of
~280mOsm. Using conventional histological methods,
confocal microscopy, and image analysis on fluorescently-
labelled fixed and living chondrocytes, we then quantified
the extent of cell shrinkage and volume change. Our data
showed that the high osmolarity of conventional fixatives
caused a shrinkage artefact to chondrocytes. This was
particularly evident when whole bones were fixed, but could
be markedly reduced if bones were sagittally bisected prior
to fixation. The shrinkage artefact could be avoided by
adjusting the osmolarity of the fixatives to the osmotic
pressure of normal extracellular fluids (~280mOsm). These
results emphasize the importance of fixative osmolarity, in
order to accurately preserve the normal volume/morphology
of cells within tissues.
Keywords: Shrinkage, artefact, osmolarity, glutaraldehyde,
para-formaldehyde, growth plate.
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Introduction
The accurate study of the morphology of living cells as
they appear within tissues is difficult but fundamental for
an understanding of normal cell biology, and the changes
that occur in disease states.  Accordingly a vast amount
of research has been performed on chemically-fixed cells
and tissues. The intention has been to retain the fine
morphology and constituents of living in situ cells so that
they can be studied without the complications of
deleterious changes to cell metabolism and loss of viability
during the investigation (see Hopwood, 1985). In addition,
tissue fixation should protect against cell autolysis, attack
by bacteria, and changes to cell volume and shape
especially during subsequent preparative treatment
(Baker, 1960) when tissue dehydration is frequently
performed. Thus, fixative solutions should serve to
stabilize the specimen and protect it from rigorous physical
tissue processing and staining as required for study
(Hopwood, 1969). Our particular research emphasis has
been on the cellular mechanisms underlying the structure
and function of the mammalian growth plate. There has
been extensive study on chemically-fixed growth plates,
and particular interest in the remarkable increase in
chondrocyte volume which is a major determinant of bone
growth (Breur et al., 1991). The large volumes of growth
plate chondrocytes (typically ranging from 1,000 to
10,000μm3; Bush et al., 2008) potentially makes them
extremely sensitive to osmotic artefacts during fixation.
Para-formaldehyde (PFA) and glutaraldehyde (GA)
and their combinations have long been used as fixative
solutions (Fox et al., 1985; Hopwood, 1969) to retain the
properties of cells and tissues (Kiernan, 1999; Renshaw,
2007). Perhaps the most widely used fixative for histology
and histopathology is 10% neutral buffered formalin
however this is not usually used for studies on the growth
plate. Examples of more conventional aldehyde
preparations used for this tissue are (a) 4% (w/v) PFA
(Fox et al., 1985; Hosoya et al., 2005; solution A, Table
1) which has the same formaldehyde concentration (4%)
as 10% Formalin (Kiernan, 1999), (b) 2% (w/v) GA &
RHT (ruthenium hexamine trichloride) combined with 2%
(w/v) PFA (Farnum et al., 2002; solution B, Table 1) and
(c) 2% GA (w/v) with 0.7% (w/v) RHT (Hunziker et al.,
1983; solution C see Table 1). Although the fixative
properties have been widely known, less appreciated is
the fact that the osmolarity of these solutions is markedly
greater than that of typical physiological extracellular
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solutions (Table 1). The osmolarity of the fixative solutions
and their effects on cell and tissue morphology have
received relatively little attention recently – indeed often
appear ignored – despite the fact that there are studies in
the literature highlighting this issue. For example, Schultz
and Karlsson (1965) observed that hypertonic fixative
solutions perfused into the central nervous system caused
cellular shrinkage and increased extracellular spaces,
whereas isotonic (300-320mOsm) and hypotonic fixatives
could result in cell swelling. Mathieu et al. (1978) have
reported the importance of both the % of GA and the
molarity of the vehicle used for the fixative solution for
the preservation of lung tissue. Even with these early
studies, there are recent examples of investigators using
hyper-osmolar fixative solutions (Farnum  et al., 2002;
Hosoya  et al., 2005) but little if any comment on the
morphology of the fixed cells which frequently appear
shrunken/distorted (Erben, 1997; Kouri  et al., 1996; Ross
and  Reith, 1985; Sanchez  et al., 2000; Van der Eerden  et
al., 2000) and little or no attempt at quantification of the
shrinkage artefact. We wished therefore (a) to re-visit this
issue and emphasize the importance of osmotic correction
to fixative solutions in order to retain cell morphology and
(b) provide quantitative data on the extent of cell shrinkage
and specifically report on the influence of fixative
osmolarity on connective tissue cells.
During preliminary experiments attempting to optimize
the fixation protocols for mammalian growth plates, we
noticed that for the same standard fixative, the appearance
of hypertrophic zone cells in histological sections from
whole bones were markedly different compared to those
from sagittally sectioned bones. The morphology of the
cells in the whole bone fixed samples appeared
considerably mis-shapen and shrunken, whereas in the
bisected bone, morphology was relatively normal. From
our previous studies on the shape/volume of chondrocytes
exposed to osmotic challenge (Bush and Hall, 2001) we
suspected that an artefact of the relatively high osmotic
pressure of the fixative solutions might account for the
abnormal chondrocyte morphology.
Thus, in the present study, we further examined using
standard and modified fixative solutions, these shrinkage
artefacts. By quantifying the osmotic shrinkage effect on
hypertrophic growth plate chondrocytes, the data
confirmed our preliminary observations that whole bones
were particularly sensitive compared to those sagittally
bisected prior to fixation. We also demonstrate that
adjusting the fixative solution to an osmolarity close to
that of typical extracellular solutions (approx. 280mOsm;
solution D, Table 1) abolishes this artefact.
Materials and Methods
Biochemicals and solutions
Unless otherwise stated, all biochemicals and solutions
were purchased from Sigma-Aldrich (Poole, U.K.) RHT
was purchased from Polysciences Inc. (Warrington, PA,
U.S.A.). Glutaraldehyde was of a grade suitable for
electron microscopy. Paraformaldehyde solution was
prepared from paraformaldehyde powder (purity of ≥95%).
The fluorescent cytoplasmic labelling dye,
chloromethylfluorescein diacetate CMFDA (CellTrackerTM
Green) and calcein AM were obtained from Invitrogen
(Paisley, U.K.) and the mounting medium, FluorSaveTM
was purchased from Calbiochem (Nottingham, U.K.)
Sodium cacodylate buffer was prepared by dissolving
sodium cacodylate trihydrate powder (assay, approx. 98%)
in distilled water, and the pH was corrected to 7.4 by
addition of HCl.
Animals and growth plate preparation
Sprague-Dawley rats (7-day-old; P7) were humanely killed
for other experiments following U.K. Home Office
guidelines. The tibia of each hind limb with intact proximal
growth plate cartilage was dissected and temporarily placed
in medium (phosphate buffered saline; PBS; approx.
293mOsm) containing alpha modified essential medium
(α-MEM; 7.5% v/v; Invitrogen) and bovine serum albumin
V (1mM), prior to fixation.
For the preparation of samples for histology, 2 tibia
from each animal were used and placed in fixative solutions
of differing composition as follows: (a) conventional
fixative solutions (Table 1), (b) fixatives with GA
concentration maintained constant, but with various
osmolarities similar to those used for conventional fixative
solutions (Table 2), and (c) fixatives with various
concentrations of GA but with osmolarity maintained at
approx. 550mOsm (Table 3). The growth plates were fixed
for 24hrs at room temperature for subsequent paraffin-
Solution 
ID Fixative solution 
Cacodylate 
buffer 
(mM) 
pH Osmolarity (mOsm) References 
A PFA 4% None 7.11 1148 ± 2 Hosoya et al., 2005 
B PFA 2% + GA 2%  + RHT 0.7% 100 7.06 1135 ± 32 Farnum et al., 2002 
C GA 2%  + RHT 0.7% 50 6.72 420 ± 20 Hunziker et al., 1983 
D GA 1.3% + RHT 0.5% 30 5.67 270 ± 10 (present study) 
Table 1. Composition of fixative solutions used in the study.
Fixative solutions were prepared as described in the references cited which reported the morphology of growth plate
chondrocytes following fixation. For solution A, distilled water was used instead of cacodylate buffer. Fixative solution
D was prepared by diluting solution C with distilled water. [Concentrations are given as % (v/v) for GA= glutaraldehyde
and PFA= paraformaldehyde, and as % (w/v) for RHT= ruthenium hexamine trichloride].
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embedding for histological sectioning. For group (a) three
intact tibias and 3 bisected tibias were fixed in each fixative
solution, whereas in group (b) and (c), three and five intact
tibias were used in each fixative solution respectively.
For the preparation of growth plates for the analysis of
in situ growth plate chondrocyte (GPC) volume, tibias from
eight P7 rat pups were grouped into: (i) five bones
maintained intact, and (ii) ten bones that were bisected
sagittally. Bones were incubated with either CMFDA-green
for 60mins (if the bones were subsequently fixed) or calcein
AM (for non-fixed bones). Then, all bones from group (i)
and four bones from group (ii) were fixed in solution A.
Three bones from group (ii) were fixed in osmotically-
corrected fixative solution (solution D, Table 1). When
appropriate, bones were fixed for 24hrs at room
temperature. The remaining 3 bones from group (ii) were
maintained unfixed for in situ living cell imaging. The
osmolarity of all solutions was determined using a freezing
point micro-osmometer (Model 3300, Vitech Scientific
Ltd., Partridge Green, U.K.) with solid NaCl or distilled
water added to adjust the osmolarity to the required range.
The pH of all solutions was measured at room temperature
using a SevenEasyTM pH meter (Mettler Toledo, UK) with
the pH of fixative solutions altered by adding either HCl
or NaOH.
Histology of the growth plate
Bones were embedded in paraffin wax using a standard
procedure (Kiernan, 1999) and tissue sections (10μm) cut
using a microtome (Reichert-Jung Microtome 2050
Supercut, Arnsberg, Germany). The sections were then
mounted on poly-l-lysine-coated microscope slides
(PolysineTM, VWR International, Leicestershire, UK) and
dried overnight. After de-paraffinisation with xylene and
rehydration with a series of ethanol solutions (100%, 90%,
75%), the sections were stained with 0.1% (w/v) Toluidine
blue O in PBS buffer (pH 5.5; 30secs at room temperature)
using the technique adapted from Bancroft and Cook
(1994). The sections were then rinsed briefly in distilled
water and allowed to air dry prior to mounting in
FluorSaveTM with cover slips.
Measurement of growth plate chondrocyte shrinkage
Histological sections of fixed hypertrophic GPC stained
with 0.1% Toluidine blue O were observed under an x63
(oil-immersion) objective lens. Several histological views
of chondrocytes within sections S5 and S6 of the
hypertrophic zone (see details in the section ‘In situ volume
measurement’ (below), and Figure 1(A)) were randomly
selected and the images recorded using a mounted digital
camera (Coolpix 4500, Nikon, Tokyo, Japan) with Coolpix
MDC2 Relay lens (MXA 2900, Nikon). The captured
images were then transferred to a computer for further
image analysis. Java-based scientific image processing
software (ImageJ, NIH, Bethesda, MD, U.S.A.) was then
used to measure the cell shrinkage from the images of the
histological sections.
In order to determine the extent of chondrocyte
shrinkage it was necessary to identify the area of individual
chondrocytes and that of their lacuna – i.e., the ‘cavity’ in
which the cell resided. It was in fact relatively
straightforward to do this as the outermost edge of the cell
area stained distinctly with Toluidine blue O, and the
perimeter of the corresponding lacuna was identified as
the edge of the extracellular matrix that demarcated the
border between the stained area of the matrix and the
‘space’ of the lacuna which was relatively unstained. It
was noted that the area of the lacuna could only be observed
if there was cell shrinkage. For each group of treatments,
4 fields of view from each growth plate section were
selected and up to 11 cells and their corresponding lacunae
randomly taken for area measurement. The area of each
Solution 
ID 
Fixative Solution Cacodylate buffer 
(mM)  pH 7.4 
pH Osmolarity 
(mOsm) 
280 0.7% RHT + 1% GA 50 6.76 273 ± 13 
480 0.7% RHT + 1% GA 50 6.60 467 ± 28 
640 0.7% RHT + 1% GA 50 6.55 637 ± 20 
1200 0.7% RHT + 1% GA 50 6.49 1141 ± 116 
 Fixative solutions were prepared with the constituents at the concentrations indicated (see Materials and Methods),
with the osmolarities and pH of the resulting solutions as shown. Concentrations are given as % (w/v) for RHT,
and % (v/v) for GA. Data expressed as means ± S.E.M. from at least 3 independent determinations.
Table 2. Modified fixative solutions with constant concentrations of GA and RHT, but with osmolarity varied using
NaCl.
Solution 
ID 
Fixatives Glutaraldehyde 
concentration (%) 
Cacodylate buffer 
(mM), pH 7.4 
pH Osmolarity 
(mOsm) 
0.5GA 0.7% RHT + GA 0.5 50 6.81 543 ± 1 
1GA 0.7% RHT + GA 1.0 50 6.73 542 ± 4 
2GA 0.7% RHT + GA 2.0 50 6.72 556 ± 18 
4GA 0.7% RHT + GA 4.0 50 6.35 577 ± 11 
Table 3. Modified fixative solutions with varying GA concentration, but with similar final osmolarity.
Fixative solutions were prepared with the constituents including different GA concentrations (% v/v) as indicated (see
Materials and Methods), with the osmolarities of the resulting solutions as shown. Concentrations of RHT are given
as % (v/v). Data expressed as means ± S.E.M from at least 3 independent determinations.
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cell and that of its associated lacuna were selected by
outlining their perimeters using the freehand selection tool
(see Fig. 2A, panel a). The total area of the cell and its
lacuna were then determined using the ‘analyze’ and
‘measure’ toolbar in the software.  Cell shrinkage was
calculated as {100 – [(cell area/lacuna area) x 100]} and
expressed as a percentage of the initial volume (see Fig.
2A, panel a). When the cell and its corresponding lacuna
shared the same perimeter, the value of cell shrinkage was
zero as defined above.
Confocal laser scanning microscopy (CLSM)
An upright Zeiss Axioskop LSM 510 (Carl Zeiss Ltd.,
Welwyn Garden City, Herts., U.K.) CLSM was used to
acquire fluorescent images of in situ hypertrophic growth
plate chondrocytes. Cells were visualized using a Plan-
Fig. 1. Overview of the rat growth plate, and division of in situ living rat chondrocytes (GPC) into sections from
proliferative to hypertrophic zones. Living chondrocytes in a bisected proximal tibia of a 7-day-old rat pup were
labelled with calcein AM, and sequential CLSM images taken with a x63 water-dipping objective (see Materials and
Methods). Panel (A) demonstrates the projected image of a section of the growth plate showing the increase in
chondrocyte volume from proliferative to hypertrophic zone. The zones were divided into eight equal sections (labelled
S1-S8) from early proliferative zone to late hypertrophic zone. Panel (B) shows the changes in the volume along the
growth plate sections as measured using Volocity® software on living in situ growth plate chondrocyte images
captured with CLSM. Also shown is an inset where the same data points were transformed to log10. (Data shown are
means ± S.E.M. or S.D. as appropriate, with n = 2 for S1-S4 and S7-S8, and n = 3 for S5-S6; and at least N=15 cells
measured at each section).
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Fig. 2A. Conventional fixatives cause considerable shrinkage of hypertrophic growth plate chondrocytes when
applied to whole (intact) bones. Intact proximal tibias of 7-day-old rat pups were fixed using various standard
fixative solutions (Table 1) and sections prepared and stained with 0.1% Toluidine blue O (see Materials and
Methods). The method used to calculate the extent of chondrocyte shrinkage was illustrated in Panel (a). The thick
white line was drawn free-hand around the perimeter of the lacuna and the black broken line drawn around the
membrane edge of its resident chondrocyte (see details in Materials and Methods). The gap between the cells and
the border of the lacuna is illustrated by double headed arrows. Cell shrinkage was observed in all conventional
fixatives (panels a - c) but not when the osmolarity of the fixative was adjusted to a ‘physiological’ osmolarity
(panel d). For pooled data see Figure 3. The scale bar of 20μm in this and the following Figure applied to all
panels.
Neofluar x10/0.3 numerical aperture (NA) dry objective
for a low power overview and an Achroplan x 63/0.95 NA
ceramic water-dipping lens for high power views.
Intracellular CMFDA was excited using an Argon laser
(Ex = 488nm) and emitted fluorescence (Em = 517nm)
detected using a 500-550nm band pass filter. The confocal
detection pinhole was set at 1.00 Airy Unit. Laser power
and detector sensitivity were adjusted to provide optimum
image quality. The scanning speed was typically 0.6Hz
with 2 frame integration of a 512 x 512 pixel image, with
serial 1 μm z-step optical sections (see Bush and Hall,
2001; Bush et al., 2007 for further details).
In situ volume measurement
Whole growth plates imaged from the proliferative to
hypertrophic zones were divided into eight equal parts and
labeled S1 to S8 (Fig. 1A). This was done so that a
comparative analysis could be made between
corresponding sections from different individuals
irrespective of variations in section cutting angle (Bush et
al., 2008). Since the greatest number of hypertrophic cells
that was consistently found to be intact was in S5 and S6,
the in situ growth plate cell volume analysis was performed
only at these sections. Chondrocytes in S7-S8 often
appeared to be in poor condition, possibly as a result of
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cutting trauma during the preparation of the tissue (Huntley
et al., 2005). Volume analysis was performed using high
performance 3D imaging software (Volocity®,
Improvision, Coventry, U.K.) on scanned CLSM images
using the calibrated cell volume method as previously
described (Bush and Hall, 2001).
Statistical analysis
Data were expressed as means ± standard error of the mean
(S.E.M), obtained from a minimum of 3 separate animals
(n), and (N) chondrocytes at each condition with the data
shown as (n[N]). Statistical significance was evaluated
using two-tailed Student’s unpaired t-tests, or ANOVA tests
as appropriate, with the P value considered significant
when P<0.05. Statistical tests were performed using
Microsoft Office Excel (Microsoft, Redmond, WA, U.S.A.)
or SigmaPlot® statistical software (Systat Software,
Chicago, IL, U.S.A.).
Results
Volume and morphology of rat growth plate
chondrocytes (GPC)
Initially, to determine live cell volumes and the morphology
of in situ, unfixed chondrocytes, we labelled in situ growth
plate chondrocytes with calcein as shown (Fig. 1). Imaging
of the fluorescently-labelled in situ living growth plate
chondrocytes demonstrated a clear increase in the size of
GPC from the proliferative through to hypertrophic zones
(Fig. 1a). Chondrocytes within the proliferative zone
(between the reserve and hypertrophic zone) appeared
Fig. 2B. Reduced cell shrinkage in GPC of bones sagittally-bisected before fixation. Bisected sections prepared
and stained with 0.1% Toluidine blue O (see Materials and Methods). With these bisected bones the extent of cell
shrinkage was markedly less compared to the intact bones (Fig. 2A) and shrunken chondrocytes were only
occasionally observed as illustrated by the double headed arrows (panel a). The morphology of chondrocytes
within the three other fixative solutions (panels b to d) was relatively normal (see pooled data in Fig. 3).
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Fig. 3A. Growth plate chondrocyte shrinkage in
histological sections from intact bones fixed in four
different solutions.  Cell shrinkage of in situ
chondrocytes fixed in solutions A, B, C or D (for
composition see Table 1) in intact tibias from 7 day-old
rats were measured as described (see Materials and
Methods). Data in this and the subsequent Figure were
from at least (3[44]) for each condition. In this and the
following Figure, P values for unpaired Student’s t-tests
are shown. (Data are given as means ± S.E.M.).
Fig. 3B. Growth plate chondrocyte shrinkage in
histological sections from bisected bones fixed in four
different solutions.  Cell shrinkage of in situ
chondrocytes fixed in solutions A, B, C or D (Table 1)
in sagittally-bisected tibias from 7 day-old rats were
measured as described (see Materials and Methods). A
single asterisk (*) denoted a significant difference when
the two-way ANOVA tested the trend of cell shrinkage
between intact and bisected bones in various fixative
solutions.  A double asterisk (**) denoted a significant
difference compared to the intact bone fixed in solution
A (Student’s unpaired t-test).
ellipsoidal and usually arranged in columns of at least three
to eight cells. In the hypertrophic zone (between the
proliferative zone and the zone of calcification) the cells
were larger and frequently more rounded although there
were cells with a height greater than the cell’s width
(Buckwalter et al., 1985; Farnum and Wilsman, 1986).
In accordance with the visual appearance of
chondrocytes along the growth plate, the quantified volume
of in situ cells increased although it was clearly not a linear
process as there was a relatively poor fit to a linear
regression (correlation coefficient r2 = 0.793). The volume
increase was initially gradual through to S5, but then
became more rapid from S5-S8 similar to an exponential
growth relationship (Fig. 1b). When the volume data were
transformed to log10 and plotted semi-logarithmically (see
inset to Fig. 1b) there was a much better fit to the data (r2
= 0.955) supporting the notion of a logarithmic increase
in chondrocyte volume associated with hypertrophy. In the
present study we focused on chondrocytes within these
latter sections of the growth plate. Although the shrinkage
artefact was apparent in the smaller cells, it was very
difficult to quantify the phenomenon using our imaging
methods (see Materials and Methods). This was because
the distinction between the perimeter of the lacuna and
the cell edges of smaller (shrunken) cells was difficult to
determine accurately, resulting in large variations.
Therefore, we decided to study the phenomenon only on
chondrocytes in the hypertrophic zone to ensure accurate
measurements, and the cells within S5-S6 were chosen
because an adequate number of intact cells from these
segments could consistently be observed.
Measurement of cell shrinkage
The accuracy of the method used for assessing chondrocyte
shrinkage in histological sections as described in Materials
& Methods (Fig. 2A panel a) was initially determined by
measuring the area of GPC cells that had distinct and well-
defined perimeters. The cell measurement was made
independently using the free-hand selection tool on the
same cell twice and the difference between the two
readings compared. The mean difference between the two
measurements was 2.7±1.9 % (mean ± standard deviation
(S.D.), for 11 cells) indicating the measurement method
had an appropriate level of accuracy.
Morphology of growth plate chondrocytes fixed
using conventional solutions
An ideal fixative should successfully preserve tissue for
subsequent staining procedures, but it is important to
accurately retain the original morphology of the living cells
in the tissue, free from artefacts occurring during the
fixation process. To demonstrate the morphology of GPC
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fixed with conventional fixatives (Farnum et al., 2002;
Hosoya et al., 2005; Hunziker et al., 1983), we used three
standard and widely-used solutions (Table 1). These
fixative solutions were all hyper-osmotic (Table 1), and
therefore for comparison an iso-osmotic fixative with
osmolarity adjusted to close to that of typical extracellular
physiological solutions (280mOsm; Table 1), was also
included.
In whole (non-bisected) bone samples, fixed and
processed as described for histology (see Materials and
Methods), there was a clear cell shrinkage artefact observed
in tissue fixed with the three conventional fixatives
(solutions A, B & C; Table 1; Fig. 2A panels a-c)). Among
the three fixatives, chondrocyte shrinkage assessed visually
was most marked for solutions A and B and least for
solution C (Fig. 2A(c)). When osmotically corrected
solution D (~280mOsm) was used, we observed no
apparent cell shrinkage (Fig. 2A panel d). Quantitatively,
solution A caused the highest cell shrinkage (44 ± 3 %
(3[44])), followed by tissue fixed in solution B (31 ± 4%
(3[44]), then cells in solution C 17 ± 5% (3[44]) and finally
for the osmotically-corrected fixative solution D, there was
no significant change in cell volume (5.5 ± 0.8% (3[44])).
When analysing the extent of the shrinkage from solutions
A to D (lowering osmolarity, Table 1), there was a
significantly decreasing trend (one-way ANOVA test;
P=0.010) however only the shrinkage for cells in solutions
A and B were significantly different (unpaired Student’s
t-test, P<0.05) from the osmotically-corrected fixative
solution D. Note that although shrunken cells were
routinely observed microscopically in cells fixed in
solution C (Fig. 2A panel c) the pooled data did not show
a significant difference and this was mainly because of
the range in the magnitude of the shrinkage effect.
In bisected bones (Fig. 2B), microscopic inspection
showed clearly that the extent of the chondrocyte shrinking
artefact was considerably reduced with the four fixatives
when compared to the cells within fixed whole bones (Fig.
2A panels a-d). When the shrinkage was quantified (Fig.
3B), the same decreasing trend in cell shrinkage with the
four fixatives was also observed and the trend significant
over the whole range (one-way ANOVA test; P=0.024).
The absolute level of shrinkage and the trend with
decreasing osmolarity, was less compared to the data for
intact bones (Fig. 3A). When the data sets for intact and
bisected bones over the range of fixatives were compared
using a two-way ANOVA, the difference was significant
(P=0.004). In solution A cell shrinkage in bisected bones
was 22 ± 2.6%, which was significantly less than the
shrinkage of chondrocytes fixed in intact tibias (P=0.030).
Fixative solution B caused 17 ± 1.4% (3[44]) shrinkage
whereas solution C caused 9 ± 0.4% (3[44]) cell shrinkage
Fig. 4A. Chondrocyte shrinkage increased with elevated
osmolarity of the fixative solution.  Whole bones were
fixed in solutions composed of 1% GA and 0.7% RHT,
with osmolarity varied over the range 273 to 1141 mOsm
by the addition of NaCl (see Table 2). Shrinkage of GPC
was determined as described (see Materials and
Methods, and Fig. 2A panel a). Data were from at least
(3[44]) for each condition and are presented as means
± S.E.M.
Fig. 4B. There was no difference in cell shrinkage with
an increase of fixative concentration if osmolarity was
kept constant. Whole bones were fixed in fixative
solutions with the GA concentration varied over the
range 0.5 to 4%, but with the osmolarity maintained
constant at ~550 mOsm (see Table 3 for composition
of solutions). Shrinkage of GPC was determined as
described (see Materials and Methods, and Fig. 2A
panel a). There was no significant difference between
any pairs of data (Student’s unpaired t-test). Data were
from at least (5[44]) for each condition and presented
as means ± S.E.M.
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and these values were less than for intact bones but did
not reach the level of significance (P>0.05). Cell shrinkage
in the iso-osmotic fixative solution D for GPC in bisected
bones was only 4 ± 0.4% (3[44]; Fig. 3) and this was not
significantly different from the data in intact bones (see
above). These results showed that the shrinkage artefact
was considerably reduced if the bones were bisected prior
to fixation, and with osmotic correction, there was no
significant shrinkage artefact of GPC in either intact or
bisected bones.
As noted in Table 1, the pH of the fixatives varied over
the range 5.67 to 7.11, which was the result of different
types and concentration of fixative agents and buffer
concentration. We conducted a further experiment to
examine whether pH contributed significantly to the quality
of tissue preservation. We tested two pH values (i.e., 5.6
and 7.2) using the same fixative solution (solution D) to
fix two groups of growth plate tissue from proximal tibia
of P7 rats (n=3). Using the same method to quantify the
cell shrinkage as described previously, the result showed
that at pH 5.7 there was 8 ± 0.6 % (mean ± S.E.M.) cell
shrinkage, whereas at pH 7.2 there was 7 ± 1.5 % of cell
shrinkage. These were not significantly different (P<0.05)
and so we concluded that pH over this range had a
Fig. 5. Reduced volume and altered morphology of in situ GPC fixed within intact bone compared to those within
bisected bones. Panels (a-c) showed the typical appearance of fluorescently (CMFDA-green)-labelled chondrocytes
within intact (panel a) or bisected (panels b, c) bones, and fixed under the various conditions indicated. The
shrinkage of some cells was observed in the fixed in situ cells (examples indicated with white arrows, panels a, b)
but not in the osmotically-corrected fixative solution D (panel c). Panel (d) shows the appearance of unfixed (i.e.,
living) in situ hypertrophic GPCs labelled with calcein. All images were taken by CLSM using a x63 water-dipping
objective. Cell volume measurements were performed as described (see Materials and Methods) with pooled data
given in Table 4. Details of the composition of fixative solutions are given in Table 1. Scale bar = 20mm.
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negligible effect on cell shrinkage compared to the
osmolarity of the fixative solutions.
Fixation of GPC using different concentrations and
osmolarities of glutaraldehyde (GA) solution
To test whether the osmolarity or concentration of fixative
was responsible for the shrinkage artefact, whole bones
were immersed in solutions with varying osmolarity (273-
1141mOsm) and standard fixative concentrations (GA 1%,
RHT 0.7%; Table 2), or in solutions varying fixative
concentration (GA 0.5-4%) whilst maintaining osmolarity
relatively constant (555± 8mOsm; Table 3). At the lowest
osmolarity (273 ± 13 mOsm), cell shrinkage was minimal
(13 ± 0.6% (3[44])), but as it was raised, there was a
progressive and significant increase (ANOVA, P<0.001)
in the extent of cell shrinkage (Fig. 4(A)). At the highest
osmolarity studied (1141mOsm) cell shrinkage was 52 ±
1.6% (3[44]) and significantly greater (unpaired Student’s
t-test, P<0.001 for both) than the shrinkage observed in
273 and 467 mOsm solutions. When the GA concentration
was varied over the range 0.5 to 4%, but with the osmolarity
of all solutions maintained constant, the shrinkage of GPC
fixed in intact bones with 1%, 2% and 4% GA was 15 ±
2.4%, 12 ± 0.5%, and 16 ± 2.1% respectively, and not
significantly different (P>0.05; data from at least (5[44]);
Fig. 4B). It was notable that GA at 0.5% showed an
apparent slightly higher cell shrinkage (25 ± 4.1% (5[44]))
compared to 1% GA, but this was not significantly different
from the lowest cell shrinkage produced by GA at 2%
(P>0.05). The morphology of a noticeable number of these
cells was abnormal, suggesting that they were not properly
fixed, and thus it was possible that the cells were
susceptible to the post-fixation dehydration protocols
(Mohamad Yusof Loqman, unpublished observations).
Taken together, these data suggest that the shrinkage and
morphological changes of GPC fixed using standard
solutions could be accounted for by the osmolarity of the
fixative solutions and not by the concentration of the
fixative.
In situ growth plate chondrocyte volume following
fixation with solution A in intact and bisected bones
The volume of in situ GPC within intact or sagittally-
bisected bones and fixed under various conditions was also
assessed using another method.  Solution A was chosen as
it had the highest osmolarity among the different
conventional fixative solutions used in the present study,
resulted in the greatest shrinkage artefact (which was easily
measured), and has been used previously in the study of
growth plate chondrocytes (see Table 1). Images of
fluorescently-labelled in situ chondrocytes taken by CLSM
showed the majority of cells with abnormal shrunken
morphology in intact bone fixed with this solution (Fig.
5a). When the bone was sagittally bisected and then fixed
using the same solution, the proportion of shrunken
chondrocytes was markedly less (Fig. 5b), and similarly
when these bones were fixed in the osmotically-corrected
solution (solution D, Table 1) there were almost no
shrunken cells observed (Fig. 5c) with the cells appearing
morphologically normal. The volume of GPC fixed in the
intact bone had a significantly reduced cell volume of
almost two and half-fold less compared to the cells in the
bisected bone (Table 4; unpaired t-test: P = 0.016, n=5).
For comparison, GPC volume of living non-fixed bone
and of bisected bones fixed in solution D were not
significantly different from the GPC volume of bisected
bone fixed in solution A (unpaired t-tests, P>0.05).
However, the volume of GPC fixed in solution A showed
no significant decrease compared to the volume of GPCs
fixed in solution D and non-fixed GPC as expected due to
cell shrinkage, as shown previously (Figure 3B). The
reason for this was not immediately obvious, although it
should be noted that the errors associated with the
measurement of in situ GPC volume were relatively large
(Table 4). In summary, the reduction in cell volume was
significantly greater for GPC within intact bones compared
to bisected bones when fixed in a conventional fixative
solution (Table 4).
Discussion
This study demonstrated that the osmolarity of fixative
solutions was of critical importance for maintaining the
normal morphology of in situ hypertrophic chondrocytes
within the mammalian growth plate following chemical
fixation. The shrinkage artefact evident when using
conventional fixatives, was abolished when the osmolarity
of the medium was reduced to close to that of normal
physiological solutions or markedly reduced when the
bones were sagittally bisected prior to fixation. These
results raise important issues in relation to the accurate
preservation of cell morphology by these widely-used
chemical fixative solutions.
The first point to consider is the identification of a
fixative concentration that ensured proper fixation of the
CMFDA-labelled in situ chondrocytes were fixed under the conditions shown (see Figure 5), their volume determined
as described (see Materials and Methods) and the pooled data presented. Data (as means ± S.E.M.) are from n = 5
animals with 5-29 chondrocytes measured from each animal. *Denotes a significant difference (P<0.05; Student’s
unpaired t-test) between the data for the intact bone and each of the data sets for the bisected bone sections.
Nature of the 
bone specimen Fixatives 
In situ GPC 
volume (µm3) 
Intact PFA 4% (solution A) 1698 ± 166* 
Bisected PFA 4% (solution A) 4064 ± 571 
Bisected GA 1.3% + RHT 0.5% (solution D) 3389 ± 659 
Bisected No fixative 3411 ± 1148 
Table 4. Reduction of in situ GPC volume in fixed intact bones compared to bisected bones.
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cells/tissue without the osmolarity being too high to cause
a shrinkage artefact and our data suggest that solution D
was optimal (Table 1; Fig. 3). This osmolarity would be
close to that normally present in physiological extracellular
solutions meaning that the osmolarity of the cells within
the extracellular matrix of the growth plate would similarly
be optimal for normal chondrocyte morphology. (Note
however that the exact extracellular osmolarity around the
GPC will most likely be higher due to the presence of
glycosaminoglycans present in the extracellular matrix
(Urban et al., 1993)). A lower concentration of GA (0.5%)
produced what appeared to be a shrinkage artefact (Fig.
4B) but although individual shrunken cells were present
on visual examination, statistical analysis of pooled data
showed this was not significant. However we would
caution against using such a low concentration as the fine
appearance of the cells suggested that there were cells that
were not properly fixed, resulting in morphological
changes/distortions during post-fixation protocols
(Mohamad Yusof Loqman, unpublished observations).
Previous studies have, however, successfully utilized low
fixative concentrations. For example Maunsbach (1966)
investigating the kidney and Hopwood (1967) studying
the brain noted that GA was an effective fixative down to
0.25% (Hopwood, 1967; Maunsbach, 1966). It is possible
that low fixative concentrations could be used successfully
in these studies because of the different physical nature of
hard tissues compared to soft tissues, as in the latter the
diffusion rate and thus penetration of the fixative would
be expected to be considerably greater. Our findings were
in general agreement with a previous report that identified
the importance of fixative osmolarity to produce correct
soft tissue preservation. Mathieu et al., (1978) reported
both the GA percentage and molarity of the fixative vehicle
were of importance for the preservation of lung tissue. In
this study, they noted the shrinkage was induced by the
osmolarity of buffer and fixative combined, as evidenced
by shape changes of erythrocytes in capillaries and small
vessels of the trachea, and a reduction in the air-blood tissue
barrier of the trachea with different fixative osmolarities.
Higher fixative concentrations (e.g. 2-4% GA) could of
course be used for some applications where cell shrinkage
is not a concern (e.g. for tissue perfusion fixation
(Santoreneos et al., 1998) or biomaterial fixation (Nuss et
al., 2006)), but clearly the results from the present study
emphasize the importance of researchers being aware of
the potential for an osmotic shrinkage artefact to cell shape.
In the present study we included RHT (ruthenium
hexamine trichloride) in most of the fixative solutions
(Table 1). Hunziker et al., (1982) have proposed that this
cationic dye stabilized the GPC plasma membrane within
the lacuna by establishing electrostatic cross-linkage
between anionic components within the plasma membrane
and the proteoglycans of the pericellular matrix which
surrounds chondrocytes. They suggested that this could
prevent the rupture or detachment of the plasma membrane
from the pericellular matrix when conventional aldehyde
solutions were used simultaneously (Hunziker et al., 1982,
1992) (Fixative solutions B and C; Table 1). In our hands
however, the presence of RHT could not prevent the
shrinkage artefact (see Fig. 3). Thus, although the %
shrinkage was not significantly different from the
osmotically-corrected fixative solution (solution D) it was
still clearly greater than the solution B & C. In addition,
we routinely observed abnormal/shrunken cells (Fig. 2A
panels b and c) as also observed in the original Hunziker
et al. (1983) study. Therefore, although it is possible that
RHT does protect against the shrinkage effect to some
extent by stabilizing the cell membrane against the
pericellular matrix, we feel that osmotic correction is the
preferred procedure to eliminate the artefact (Fig. 3) and
the presence of any abnormal cells (Fig. 2A panel d).
The nature of the chemical fixative is also an issue of
importance as there is not one fixative suitable for all
applications. For example, GA has been associated with
antigen masking due to its excessive and aggressive cross-
linking of proteins, and is therefore normally considered
unsuitable for tissues intended for immunochemical
staining (Renshaw, 2007). GA is usually used as a mixture
with PFA termed Karnovsky’s fixative (Karnovsky, 1965)
so as to take advantage of the latter which has rapid tissue
penetration although the fixation rate is not as rapid as
that of GA (Kiernan, 1999). Our view is that PFA (4%)
alone, probably gives the best compromise between good
cytological preservation and immunolocalization, while
at the same time maintaining antigen masking to a
minimum. However, as it is a fixative solution with high
osmolarity (Table 1), tissues should be bisected beforehand
to maximize rapid fixative access to limit undesirable cell
shrinkage artefacts although it should be noted that they
were still clearly apparent (Fig. 2B panel a) and still
significant (~20% shrinkage, Fig. 3). We note that although
10% neutral buffered formalin is rarely used in growth
plate studies, it is a widely used fixative for routine
histology and histopathology (Renshaw, 2007). However
it should be noted that its osmolarity (measured at approx.
1700mOsm; Mohamad Yusof Loqman, unpublished
observations) is even higher than the fixatives used here
and thus we would expect that the artefactual shrinkage
would be even more marked than reported for solution A
(4% PFA).
The finding that the shrinkage artefact was significantly
reduced in bisected compared to whole bones, strongly
suggested that the rate of penetration of the fixative
compared to the osmotic changes to chondrocytes resulting
from the high osmolarity of the fixative solutions are
important. In the whole bone, the large shrinkage artefact
suggested that osmotically-induced cell shrinkage occurred
before the tissue was fixed. Thus when the bone was placed
in the fixative solution, water movement out of the bones
to the hyper-osmolar fixative solution occurred rapidly,
and before the fixative fully penetrated the bone/cartilage
matrix to fix the cells throughout the sample. Dempster
(1960) has shown that fixatives obeyed the diffusion laws,
that is, the depth penetrated (d) was proportional to the
square root of time and the coefficient of diffusibility of
the fixative, which was specific for each fixative. As the
diffusion is directly proportional to the concentration
gradient based on Fick’s Law (Mehrer, 2007), the
diffusibility of the fixative molecules (PFA, FA, GA)
through the extracellular matrix of the tissue will
undoubtedly be less than that for water molecules because
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of their different molecular shape and molecular weight.
Thus, the diffusibility of the fixatives will be markedly
less than that of water, leading to a greater shrinkage effect
in thicker and denser tissues such as bone/cartilage,
compared to ‘soft’ tissues such as brain and kidney. For
thick tissues where preservation of cell morphology deep
in the tissue is of importance, osmotic adjustment with
lower fixation concentrations and longer fixation times
would be advisable. Most workers set the fixation period
using conventional fixatives of between 1- 4 hrs, or even
longer (Hopwood, 1969). The optimum time will depend
on several factors including the physical properties of the
tissue (e.g. bone/cartilage vs. brain) concentration of the
fixative and thickness of tissue sections. Higher fixative
concentration requires shorter fixation times (Monis et al.,
1965) whereas thicker blocks and harder tissues will
necessitate longer fixation times as the penetration of the
fixative will be slower.
Our results demonstrated that the shrinkage artefact
could also be significantly reduced – although not
abolished – when the bone was bisected before being fixed
in standard (high osmolarity) fixative solutions (Fig. 3).
Bone bisection would markedly reduce the physical
obstacles and diffusional distances thereby providing a
more direct and far more rapid exposure of the GPC that
were being visualized to the fixative solutions. The rate of
fixation would thus be much more rapid compared to GPC
within intact bone, although the fact that the shrinkage
artefact was still present indicated that despite the increased
access provided to the fixative, significant cell shrinkage
still occurred before the tissue was effectively fixed (Fig.
3). However, the drawback with bone bisection as a
manoeuvre to reduce the fixation artefact would be that it
could cause physical trauma/death to the cells at the cut
edge (Huntley et al., 2005) and unless care was taken with
imaging protocols by optically sectioning deeper into the
tissue, the damaged surface cells would be the ones that
are visualized. Bone bisection would also release internal
(physiological) pressures within the bone and result in the
loss/damage to matrix constituents (loss of proteoglycans,
damage to the collagenous network, altered ionic/osmotic
environment) potentially leading to changes to the in vivo
properties (volume/morphology) of chondrocytes prior to
fixation (Guilak  and  Mow, 2000).
Our measurements of cell shrinkage by a histological
method (Fig. 2A,B; Fig. 3) were supported to some extent
by volume analysis of fluorescently-labelled living in situ
GPC images taken by CLSM (Fig.5 and Table 4). Although
the latter technique was more time-consuming, it served
as a useful additional and direct measure of cell volume to
confirm the cell shrinkage due to hyper-osmolar fixatives.
The results from this method clearly showed the reduction
in the cell volume of chondrocytes fixed with PFA (4%)
in intact bone compared to bisected bone (Table 4). We
would have expected that in parallel with the histological
shrinkage measurements (Fig. 3A, B), the volume of cells
within the bisected bone samples would not have been
reduced in the PFA solution to the same extent as cells
fixed with the osmotically-corrected fixative solution. At
present we do not have an explanation for this finding, but
note that we did not find the volume method was as
sensitive for detecting the chondrocyte shrinkage compared
to the histological method.
Both of these approaches provided us with more
accurate quantitative measurements of the cell shrinkage
artefact, compared to previous indirect methods e.g.
counting the number of cell nuclei per unit area of tissue
(Fox et al., 1985).  Previous studies had suggested fixation
artefacts arose from subsequent steps in tissue processing
e.g. during ethanol-induced dehydration and embedding
(Hopwood, 1969). However our data suggested that before
it was possible to determine these secondary artefacts
resulting from further preparation of tissue for histological
analysis, it was essential that as far as possible the fixed
tissue was close to its native state by abolishing the osmotic
shrinkage artefact reported here.
In summary, our study demonstrated that the high
osmolarity of conventional fixatives caused a shrinkage
artefact to chondrocytes within the hypertrophic zone of
the mammalian growth plate. This was particularly
noticeable when whole bones were fixed, but was still
present when the bones were bisected prior to fixation.
This problem could be avoided by adjusting the osmolarity
of the fixatives to the osmotic pressure of normal
extracellular fluids (~280mOsm). In conclusion, in order
to preserve the normal volume/morphology of cells within
tissue samples, careful consideration should be given to
the osmotic pressure of the fixative solution.
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Discussion with Reviewer
Reviewer I: 10% Neutral Buffered Formalin is probably
the most widely used fixative for routine histology and
histopathology. Was this fixative tested at all? Did the
authors simply concentrate on fixatives considered specific
for growth plates?
Authors: While 10% Neutral Buffered Formalin (also
referred to as 4% formaldehyde (Renshaw, 2007)) is widely
used for processing tissues for routine histology, its use in
growth plate tissue fixation is rather uncommon compared
to other conventional fixatives as tested in the present study.
Accordingly we have not focussed on this fixative. We
note that the osmolarity of the 10% neutral phosphate
buffered formaldehyde solution measured in our laboratory
was ~1700mOsm, and thus much higher than the
osmolarity of the fixatives used in the present investigation.
We would expect that the artefactual shrinkage produced
by this fixative would be much more marked, and have
included a comment on the use of this commonly used
fixative compared to the other fixatives used in our study.
